Fresenius SE & Co (FSNUY) Price & Analysis

Compare

93 Followers

FSNUY Stock Chart & Stats

$14.04

$0.06(0.63%)

At close: Jan 08 4:00 PM EST

$14.04

$0.06(0.63%)

Day’s Range― - ―

52-Week Range$9.54 - $15.39

Previous CloseN/A

Volume6.04K

Average Volume (3M)1.96K

Market Cap

$33.97B

Enterprise Value$40.50B

Total Cash (Recent Filing)$2.37B

Total Debt (Recent Filing)$13.58B

Price to Earnings (P/E)27.1

Beta0.24

Next Earnings

Feb 25, 2026

EPS Estimate

0.27

Next Dividend Ex-DateN/A

Dividend Yield1.97%

Share Statistics

EPS (TTM)0.18

Shares Outstanding2,252,949,200

10 Day Avg. Volume0

30 Day Avg. Volume1,958

Financial Highlights & Ratios

PEG Ratio-0.89

Price to Book (P/B)3.90

Price to Sales (P/S)3.49

P/FCF Ratio49.97

Enterprise Value/Market Cap1.19

Enterprise Value/Revenue1.81

Enterprise Value/Gross Profit7.26

Enterprise Value/Ebitda11.59

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue GrowthConsistent revenue growth indicates strong market demand and effective business strategies, supporting long-term expansion and stability.

Operational ExecutionEffective cost management and operational execution enhance profitability, providing a solid foundation for sustainable growth.

Cash Flow GenerationStrong cash flow generation enhances financial flexibility, enabling strategic investments and debt reduction, bolstering long-term resilience.

Bears Say

Macroeconomic ChallengesPersistent macroeconomic and geopolitical challenges can impact operational costs and revenue, posing risks to sustained growth.

DRG Inflator In GermanyLower DRG inflator projections may reduce revenue growth in Germany, affecting the profitability of the hospital management segment.

Impact Of U.S. TariffsU.S. tariffs increase costs for Kabi, particularly in MedTech, potentially squeezing margins and impacting competitive positioning.

Fresenius SE & Co News

Fresenius SE price target raised to EUR 57 from EUR 52 at Citi

Citi raised the firm’s price target on Fresenius SE (FSNUY) to EUR 57 from EUR 52 and keeps...

18d ago

Fresenius SE price target lowered to EUR 56 from EUR 57 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on Fresenius SE (FSNUY) to EUR 56 from EUR 57 and...

25d ago

Fresenius SE price target raised to EUR 57 from EUR 56 at Morgan Stanley

Morgan Stanley analyst Robert Davies raised the firm’s price target on Fresenius SE (FSNUY) to EUR 57 from...

2M ago

Fresenius SE price target raised to EUR 56 from EUR 53 at Deutsche Bank

Deutsche Bank raised the firm’s price target on Fresenius SE (FSNUY) to EUR 56 from EUR 53 and...

3M ago

Fresenius SE Earnings Call Highlights Strong Growth

Fresenius Se (($FSNUY)) has held its Q3 earnings call. Read on for the main highlights of the call....

4M ago

Fresenius SE price target raised to EUR 53.60 from EUR 49.10 at JPMorgan

JPMorgan raised the firm’s price target on Fresenius SE (FSNUY) to EUR 53.60 from EUR 49.10 and keeps...

4M ago

Fresenius SE Reports Strong Q3 2025 Performance

Fresenius Se ( ($FSNUY) ) has released its Q3 earnings. Here is a breakdown of the information Fresenius...

4M ago

Fresenius SE price target raised to EUR 53 from EUR 52 at Deutsche Bank

Deutsche Bank raised the firm’s price target on Fresenius SE (FSNUY) to EUR 53 from EUR 52 and...

4M ago

Fresenius SE price target raised to EUR 50 from EUR 48 at Morgan Stanley

Morgan Stanley analyst Robert Davies raised the firm’s price target on Fresenius SE (FSNUY) to EUR 50 from...

6M ago

Fresenius SE Earnings Call: Growth Amid Challenges

Fresenius Se (($FSNUY)) has held its Q2 earnings call. Read on for the main highlights of the call....

6M ago

Fresenius SE Reports Strong Q2 2025 Earnings

Fresenius Se ( ($FSNUY) ) has released its Q2 earnings. Here is a breakdown of the information Fresenius...

7M ago

Fresenius SE price target raised to EUR 52 from EUR 43 at Citi

Citi raised the firm’s price target on Fresenius SE (FSNUY) to EUR 52 from EUR 43 and keeps...

9M ago

Fresenius SE price target raised to EUR 48 from EUR 44 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Fresenius SE (FSNUY) to EUR 48 from EUR 44 and...

9M ago

Fresenius SE price target raised to EUR 50 from EUR 45 at Berenberg

Berenberg raised the firm’s price target on Fresenius SE (FSNUY) to EUR 50 from EUR 45 and keeps...

9M ago

FSNUY FAQ

What was Fresenius SE & Co’s price range in the past 12 months?

Fresenius SE & Co lowest stock price was $9.54 and its highest was $15.39 in the past 12 months.

What is Fresenius SE & Co’s market cap?

Fresenius SE & Co’s market cap is $33.97B.

When is Fresenius SE & Co’s upcoming earnings report date?

Fresenius SE & Co’s upcoming earnings report date is Feb 25, 2026 which is in 4 days.

How were Fresenius SE & Co’s earnings last quarter?

Fresenius SE & Co released its earnings results on Nov 05, 2025. The company reported $0.178 earnings per share for the quarter, missing the consensus estimate of $0.208 by -$0.03.

Is Fresenius SE & Co overvalued?

According to Wall Street analysts Fresenius SE & Co’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Fresenius SE & Co pay dividends?

Fresenius SE & Co pays a Annually dividend of $0.283 which represents an annual dividend yield of 1.97%. See more information on Fresenius SE & Co dividends here

What is Fresenius SE & Co’s EPS estimate?

Fresenius SE & Co’s EPS estimate is 0.27.

How many shares outstanding does Fresenius SE & Co have?

Fresenius SE & Co has 2,252,949,200 shares outstanding.

What happened to Fresenius SE & Co’s price movement after its last earnings report?

Fresenius SE & Co reported an EPS of $0.178 in its last earnings report, missing expectations of $0.208. Following the earnings report the stock price went down -1.083%.

Which hedge fund is a major shareholder of Fresenius SE & Co?

Currently, no hedge funds are holding shares in FSNUY

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Fresenius SE & Co Stock Smart Score

Neutral

Blogger Sentiment

Bullish

FSNUY Sentiment 70%
Sector Average 70%

Technicals

Fundamentals

Return on Equity

7.22%

Trailing 12-Months

Asset Growth

5.51%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Fresenius SE & Co

Fresenius SE & Co. KGaA is a global healthcare group based in Germany, operating in the sectors of dialysis, hospital management, and pharmaceuticals. The company is primarily known for its medical devices and services related to renal care, particularly through its Fresenius Medical Care division, which is the world's largest provider of dialysis products and services. Additionally, Fresenius operates in the pharmaceutical sector via Fresenius Kabi, focusing on injectable drugs and clinical nutrition, and in hospital management through Fresenius Helios, which manages a network of hospitals in Germany.

Fresenius SE & Co (FSNUY) Earnings & Revenues

Historic Earnings Reports

FSNUY Company Deck

FSNUY Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

Fresenius demonstrated strong performance across its core businesses, with significant EPS growth and an EBIT guidance upgrade. Despite facing macroeconomic and geopolitical challenges, the company maintained strong operational execution, particularly in its Kabi and biopharma segments. The DRG inflator in Germany and U.S. tariffs present potential headwinds, but the overall momentum remains positive.View all FSNUY earnings summaries